A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer (MONARCH 2)

Start of enrollment: 2014 Jul 01 Panwalkar, A.,Tiersten, A.,WHITTENBERGER, B.,Stokoe, C.,Jones, C.,Patt, D.,Tamkus, D.,Khan, D.,Khan, F.,Holmes, F.,Wright, G.,Sledge, G.,Wang, G.,Koh, H.,Soliman, H.,Rugo, H.,Reynolds, J.,Vu, J.,Beck, J.,...

A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer (JUNIPER)

Start of enrollment: 2014 Oct 01 DiCarlo, B.,Bastos, B.,Initiatives, C.H.,Jones, C.,Carter, C.,Martincic, D.,Daniel, D.,Kanamori, D.,Spigel, D.,Waterhouse, D.,Townsend, D.,Santos, E.,Roman, E.,Schaefer, E.,Khan, F.,Kloecker, G.,Mirshahid...

A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen (CheckMate153)

Start of enrollment: 2014 Feb 01 Melnyk, A.M.,Marek, B.J.,Chakmakjian, C.,Taboada, C.,Henderson, C.A.,Butler, C.,Jones, C.,Reynolds, C.,Daniel, D.,Hakimian, D.,Spigel, D.,Waterhouse, D.,Watkins, D.,Lindquist, D.,Lowenthal, D.,Slater, D.,...